Products

DenSeeMammo
Statlife
Oncology AI
DenSeeMammo by Statlife is an FDA-cleared AI software for automated and standardized breast density assessment in digital mammography, aiding radiologists with BI-RADS 5th Edition categories.

See all 1 product →

About Statlife

SaveLife.AI is a physician-led artificial intelligence (AI) company dedicated to revolutionizing healthcare by delivering clinically validated and accessible solutions. Their core mission is to enhance diagnostic precision, optimize clinical workflows, and democratize access to life-saving care globally. The company focuses on developing applied AI solutions to address significant healthcare challenges, aiming to make a lasting, positive impact on patient outcomes worldwide.

Their approach centers on practical, real-world implementation of AI, particularly emphasizing accessibility in underserved regions. SaveLife.AI upholds rigorous standards for accuracy, reliability, and data security in all its offerings. They actively collaborate with clinicians and institutions to ensure seamless integration and user-centric design of their products, striving to transform patient data into insightful, research-driven formats for clearer clinical understanding.

For physicians, SaveLife.AI offers tools designed to improve efficiency and accuracy in medical imaging and documentation. Their products aim to reduce radiologist burnout through lightning-fast radiology reporting and enhance clinical documentation with smart suggestions to reduce denial rates and close billing gaps. The company’s solutions are built to integrate with existing systems, providing comprehensive clinical data insights and supporting a shift towards more intelligent and efficient patient care.

Focus Areas

Predictive Medicine Preventive Medicine Personalized Medicine Participatory Medicine (4P Medicine) Breast Cancer Risk Assessment Breast Density Assessment Statistical Data Mining AI in Healthcare Multi-pathology Predictive Tests

Business Intelligence

Key InvestorsPublicly traded shareholders
PartnershipsGustave-Roussy Institute, Breast Cancer Surveillance Consortium (BCSC), MyPeBS study (European Union), Precision Genetics
AcquisitionsMammoRisk and DenSeeMammo are products of Predilife; Predilife has not made other reported acquisitions.
TechnologyAI-based "nearest neighbor" method, non-parametric calculation, Big Data, combines clinical data, imaging (breast density), and genetic data (polygenic score).
FDA ClearancesAt least 3 (MammoRisk, DenSeeMammo for GE systems, DenSeeMammo for Hologic systems), with DenSeeRisk submission underway. cleared products (estimated)

What Physicians Need to Know

Predictive Medicine
Statlife specializes in predicting disease risk, notably through its MammoRisk tool for breast cancer. This involves leveraging data to forecast individual health trajectories and potential disease development.
Preventive Medicine
By providing early and accurate risk assessments, Statlife's solutions aim to enable proactive interventions and preventive strategies, aligning with the principles of preventing serious diseases before symptoms occur.
Personalized Medicine
The company focuses on tailoring medical approaches based on individual patient data, such as breast density and other risk factors, to offer more precise and relevant health insights.
Participatory Medicine (4P Medicine)
Statlife's tools support patient engagement by providing clear risk information, empowering both patients and physicians to make informed decisions about health management and lifestyle changes.
Breast Cancer Risk Assessment
A core specialization is the assessment of breast cancer risk using tools like MammoRisk, which can be combined with breast density evaluations to provide a comprehensive risk profile.
Breast Density Assessment
Statlife offers DenSeeMammo, an FDA-cleared software that provides standardized and automatic breast density evaluation according to BI-RADS guidelines.
Statistical Data Mining & AI in Healthcare
The company utilizes statistical data mining and artificial intelligence to analyze complex medical data, enabling accurate predictions and automated assessments for disease risk and diagnostic support.
Multi-pathology Predictive Tests
While specific product details are less prominent in available information beyond breast cancer, Statlife's stated specialization in predictive medicine suggests an application of its data mining and AI capabilities across various pathologies to identify risks and predict outcomes.
Physician Tip

For physicians, Statlife offers objective and standardized tools for breast density assessment (DenSeeMammo) and integrated breast cancer risk evaluation (MammoRisk). These tools can significantly enhance personalized screening recommendations and facilitate shared decision-making with patients. The automated nature of DenSeeMammo, cleared by the FDA, ensures consistent and reliable breast density classification according to BI-RADS guidelines, which is crucial for identifying women who may benefit from supplemental screening. By combining density assessment with a comprehensive risk score, physicians can gain a more holistic view of a patient's risk profile, potentially leading to earlier interventions and improved patient outcomes.

Statlife's DenSeeMammo software is noted for its compatibility with GE Healthcare's Senographe Essential mammography systems, indicating a focus on integrating with existing clinical imaging infrastructure. This suggests a design philosophy aimed at seamless incorporation into established radiology workflows. Further integrations would likely involve electronic health record (EHR) systems to leverage patient data for predictive analytics and to deliver risk assessments directly within the physician's workflow.

Products by Statlife

1 product in the directory

DenSeeMammo
Statlife
Oncology AI
DenSeeMammo by Statlife is an FDA-cleared AI software for automated and standardized breast density assessment in digital mammography, aiding radiologists with BI-RADS 5th Edition categories.

Reviews & Opinions

No web reviews on file yet for Statlife. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Statlife.

Loading videos...

Videos load interactively. If none appear, search YouTube for Statlife →

View all on YouTube

Press & Coverage

Business Recorder
State Life: Putting Policyholders First Redefining the Insurance Landscape with Innovation and Growth
State Life demonstrated its commitment to policyholders by fulfilling a substantial portion of insurance claims, accounting for 73% of total claims paid by the industry in 2023. The company also focuses on digital enhancements and product innovation for diverse customer segments.
2023-06
State Life Insurance
State Life and JS Bank Partner to Expand Access to Insurance Across Pakistan
State Life Insurance Corporation (SLIC) and JS Bank have partnered to broaden insurance access across Pakistan. This is part of several strategic collaborations by SLIC to strengthen the agricultural sector and expand health programs.
2026-05
The News International
State Life reports Rs26bn profit, declares Rs181bn bonus to policyholders
The State Life Insurance Corporation of Pakistan (SLIC) reported a profit before tax of Rs26 billion for 2025 and announced Rs181 billion in bonuses for policyholders. Total income exceeded Rs640 billion, with premium income reaching Rs289 billion.
2026-05
State Life Insurance
2026: ACCELERATING MOMENTUM, LEADING WITH INNOVATION
State Life is set for a year of accelerated financial protection for Pakistanis through innovation, diversification, and enhanced policyholder convenience. Key initiatives include Shariah-compliant pension plans and expanded health coverage.
2026-03
TechJuice
State Life Pakistan's Digital Infrastructure Allegedly Exposed Due to Major Security Misconfigurations
Pakistan's State Life Insurance Corporation is reportedly facing cybersecurity concerns due to improperly secured public-facing systems, potentially exposing sensitive infrastructure. An independent security researcher highlighted insecure deployment practices and weak security configurations.
2026-05
The News International
State Life builds digital, service capacity to expand universal health benefits to entire Pakistan
The State Life Insurance Corporation of Pakistan (SLIC) has developed expertise in delivering universal health insurance coverage to 180 million residents across three provinces. They are positioned to expand customized insurance benefits nationwide, ensuring broader access to healthcare.
2025-04
Google Play
StateLife Health Plus - Apps on Google Play
StateLife Health Plus is a mobile application designed to empower users in managing their healthcare. It offers features such as instant access to policy details, exclusive discounts at partner facilities, and simplified claim reimbursement.
2026-06
ProPakistani
Cabinet Approves Increase in Paid-up Capital of State Life Insurance Corporation
The Federal Cabinet approved an increase in the paid-up capital of the State Life Insurance Corporation (SLIC) by Rs. 1.8 billion, raising it from Rs. 6.2 billion to Rs. 8 billion. This decision addresses regulatory requirements, particularly for operating in the UAE.
2024-01

Frequently Asked Questions

Statlife's MammoRisk and DenSeeMammo software are designed to advance 4P Medicine by providing personalized breast cancer risk assessment and density evaluation. MammoRisk integrates individual risk factors to predict future breast cancer risk, enabling preventive strategies and personalized screening programs. This approach empowers both physicians and patients to participate in tailored healthcare decisions.
Statlife offers MammoRisk for breast cancer risk assessment and DenSeeMammo for automated breast density assessment. MammoRisk uses a 'nearest neighbor' method to evaluate risk based on factors like age, breast density, and family history, while DenSeeMammo provides BI-RADS 5th Edition density assessments immediately after mammography. These products can be used individually or combined for a comprehensive evaluation.
Statlife specializes in statistics and data mining, utilizing a proprietary 'nearest neighbor' method for its MammoRisk breast cancer risk assessment. This method compares a patient's characteristics to a large database of women to predict individual risk with high accuracy. DenSeeMammo also employs imaging comparison technology, mimicking a radiologist's visual reading for breast density assessment.
Yes, Statlife's DenSeeMammo breast density assessment software is CE marked and has received FDA 510(k) clearance for use with General Electric Senographe Essential mammography systems. The company is actively working to expand its clearance to include most other mammography systems currently available.
While Statlife is described as developing 'risk prediction solutions for personalized medicine' for various pathologies, their currently highlighted and detailed products, MammoRisk and DenSeeMammo, are specifically focused on breast cancer risk assessment and breast density evaluation. This indicates a primary focus on breast health solutions at present.
Statlife's software is intended for a range of healthcare professionals, including radiologists, breast surgeons, gynecologists, and primary care physicians. They developed their software in collaboration with institutions like the Gustave-Roussy Institute and have integrated MammoRisk into several imaging centers, suggesting ongoing partnerships and support for implementation.
Founded in 2004, Statlife has been operating for over two decades in the medical software and data mining sector. Their successful development of FDA-cleared and CE-marked products, along with collaborations with major cancer research centers and adoption by imaging centers, indicates a sustained presence and commitment to the healthcare AI market.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]

Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.